Plasma Cytokine Levels Distinguish Chronic Graft Versus Host Disease (cGVHD) Symptom Profile Groups

Understanding the biologic milieu associated with differing symptom profiles in allogeneic HSCT survivors with cGVHD has the potential to clarify the pathogenesis of cGVHD activity and tissue damage, and may direct the development of new strategies to ameliorate symptoms and improve quality of life.